Major Shareholder Group Restructures, Consolidating Control of 37.6% Stake

summarizeSummary

An amendment to Schedule 13D reveals a significant internal restructuring within the major shareholder group, Hainan Oriental Jiechuang Investment Partnership, which holds a 37.6% stake in Aesthetic Medical International Holdings Group Ltd.

check_boxKey Events

• Major Shareholder Restructuring

  Hainan Oriental Jiechuang Investment Partnership, a key entity within the reporting group holding a 37.6% stake, underwent an internal restructuring that closed on March 26, 2026.

• Changes in Partnership Composition

  The restructuring involved new entities subscribing to shares in Jiechuang, and the withdrawal of several previous partners, including Lafang Investment, SVC Fund Management, Red Earth, and SCGC.

• Consolidation of Control

  Zheng Qingying, an individual within the reporting group, became a general partner of Jiechuang, consolidating control over the significant ownership stake.

• Continued Significant Ownership

  Despite the internal changes, the key individuals Zheng Qingying and Wu Guiqian continue to collectively beneficially own 57,815,846 ordinary shares, representing 37.6% of the company's outstanding shares.

auto_awesomeAnalysis

This Schedule 13D/A details recent changes in the composition and control of a significant investor group. The restructuring, which closed on March 26, 2026, involved new entities subscribing to shares in Hainan Oriental Jiechuang Investment Partnership and the withdrawal of several previous partners. Notably, Zheng Qingying has become a general partner, consolidating control within the group. While the overall beneficial ownership percentage of 37.6% held by key individuals Zheng Qingying and Wu Guiqian remains unchanged, this internal reorganization of such a dominant shareholder group is important for understanding the company's long-term governance and potential strategic direction.